Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Einzigartiges Zentrum
Universidad de Castilla-La Mancha
Ciudad Real, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidad de Castilla-La Mancha (27)
2024
-
Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation
Schizophrenia Bulletin, Vol. 50, Núm. 2, pp. 327-338
2023
-
Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
Psychiatry Research, Vol. 323
-
Targets, Mechanisms and Cytotoxicity of Half-Sandwich Ir(III) Complexes Are Modulated by Structural Modifications on the Benzazole Ancillary Ligand
Cancers, Vol. 15, Núm. 1
2022
-
A replication study of JTC bias, genetic liability for psychosis and delusional ideation
Psychological Medicine, Vol. 52, Núm. 9, pp. 1777-1783
-
Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway
Psychological Medicine, Vol. 52, Núm. 10, pp. 1910-1922
-
Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 113
-
The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
European Neuropsychopharmacology, Vol. 63, pp. 47-59
2021
-
A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin
Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 524-545
-
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543
-
Correction to: A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin (Drug Delivery and Translational Research, (2021), 11, 2, (524-545), 10.1007/s13346-021-00920-x)
Drug Delivery and Translational Research
-
Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e25
2020
-
Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum
Epidemiology and Psychiatric Sciences
-
In vitro relevant information for the assessment of nanoparticles for oral drug administration
Nanotechnology for Oral Drug Delivery: From Concept to Applications (Elsevier), pp. 419-458
-
Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study
Psychological Medicine, Vol. 50, Núm. 11, pp. 1884-1897
2019
-
Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study
Schizophrenia bulletin, Vol. 45, Núm. 5, pp. 960-965
-
Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study
World Psychiatry, Vol. 18, Núm. 2, pp. 173-182
-
White noise speech illusions: A trait-dependent risk marker for psychotic disorder?
Frontiers in Psychiatry, Vol. 10, Núm. SEP
2018
-
Functionalized Polymeric Nanostructures for Mucosal Drug Delivery
Biomedical Applications of Functionalized Nanomaterials: Concepts, Development and Clinical Translation (Elsevier), pp. 449-487
-
Influence of the surface properties of nanocapsules on their interaction with intestinal barriers
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 133, pp. 203-213
-
PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy
Journal of Controlled Release, Vol. 276, pp. 125-139